Antonio Cubillo Gracián
- 36 years of experience
- Location: Spain, Madrid
Dr. Antonio Cubillo Gracián pioneered the first liquid biopsy program in Spain. He uses genetic data to guide KRAS, NRAS, and BRAF mutation testing for targeted therapy.
- Heads the Medical Oncology Service at Hospital Universitario HM Sanchinarro
- Directs postgraduate research at HM CIOCC, a leading Spanish cancer center
- Uses molecular markers like EGFR and ALK to design personalized cancer treatment plans
- Leads clinical trials for new cancer therapies through the Start Madrid program
- Member of the teacher faculty at USP CEU medical school
- Read more





